GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹40 Cr | ₹30 Cr | ₹24 Cr | ₹19 Cr | ₹21 Cr |
What is the latest Total Current Liabilities ratio of GENNEX LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹40 Cr |
Mar2023 | ₹30 Cr |
Mar2022 | ₹24 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹21 Cr |
How is Total Current Liabilities of GENNEX LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹40 Cr | 36.57 | |
Mar2023 | ₹30 Cr | 21.91 | |
Mar2022 | ₹24 Cr | 27.25 | |
Mar2021 | ₹19 Cr | -8.79 | |
Mar2020 | ₹21 Cr | - |
Compare Total Current Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹404.3 Cr | 8.9% | -5.8% | 9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,145.0 Cr | -2% | 2.1% | 42.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,280.0 Cr | -3.5% | -3.4% | 49.9% | Stock Analytics | |
CIPLA | ₹120,379.0 Cr | -2.6% | -0.6% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,701.0 Cr | -2.7% | 8.9% | 14.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,774.5 Cr | -1% | -1.7% | 36.9% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | 8.9% |
-5.8% |
9% |
SENSEX | -0.4% |
-3.7% |
7.9% |
You may also like the below Video Courses